| |
| |
|
| Insider
Information: |
Robb Gary Charles |
| Relationship: |
|
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
20,203 |
|
|
Indirect Shares
|
25,100 |
|
|
| Direct
Value |
$513,156 |
|
|
|
Indirect Value
|
$637,540 |
|
|
| Total
Shares |
45,303 |
|
|
| Total
Value |
$1,150,696 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
18
|
|
Stock
price went up :
|
0
|
10
|
| Stock
price went down : |
0
|
8
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.3
|
| Percentage
Gain/Loss : |
0.0%
|
 -2.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Corcept Therapeutics Inc |
CORT |
|
2024-03-01 |
20,203 |
2024-03-01 |
25,100 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
59 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
• – – |
2017-09-05 |
4 |
GA |
$0.00 |
$0 |
I/I |
2,460 |
820 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Financial OfficerOfficer |
• – – |
2011-09-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,258 |
|
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
• – – |
2017-12-26 |
4 |
GA |
$0.00 |
$0 |
I/I |
2,244 |
1,568 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-12-26 |
4 |
GA |
$0.00 |
$0 |
I/I |
3,501 |
2,735 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-11-16 |
4 |
GA |
$0.00 |
$0 |
I/I |
2,487 |
4,564 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
• – – |
2017-05-04 |
4 |
B |
$9.75 |
$54,588 |
D/D |
5,600 |
6,858 |
2.74 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-12-12 |
4 |
S |
$19.01 |
$475,153 |
D/D |
(25,000) |
6,858 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-12-13 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,000) |
7,700 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-12-26 |
4 |
GA |
$0.00 |
$0 |
D/D |
1,167 |
8,025 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
• – – |
2019-12-09 |
4 |
S |
$13.73 |
$412,029 |
D/D |
(30,000) |
8,025 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-06-08 |
4 |
GA |
$0.00 |
$0 |
I/I |
2,175 |
8,061 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-12-08 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,917 |
8,700 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2024-03-01 |
4 |
D |
$24.06 |
$15,783 |
D/D |
(656) |
18,809 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$31,776 |
D/D |
3,200 |
19,583 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-05-10 |
4 |
S |
$24.07 |
$336,980 |
D/D |
(14,000) |
19,997 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-06-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
600 |
20,029 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2024-03-01 |
4 |
A |
$0.00 |
$16,770 |
D/D |
1,394 |
20,203 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-06-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,550 |
20,629 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-12-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
750 |
20,640 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-09-01 |
4 |
A |
$0.00 |
$16,550 |
D/D |
1,000 |
21,029 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2022-11-23 |
4 |
S |
$26.03 |
$4,842 |
D/D |
(186) |
21,143 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2022-11-22 |
4 |
S |
$26.03 |
$125,308 |
D/D |
(4,814) |
21,329 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-12-06 |
4 |
S |
$27.01 |
$167,786 |
D/D |
(6,212) |
21,390 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-12-12 |
4 |
OE |
$1.92 |
$48,000 |
D/D |
25,000 |
21,858 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-09-19 |
4 |
S |
$32.74 |
$163,677 |
D/D |
(5,000) |
21,996 |
0 |
% |
|
59 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
